138 related articles for article (PubMed ID: 9300728)
1. DNA-binding antibodies from viable motheaten mutant mice: implications for B cell tolerance.
Westhoff CM; Whittier A; Kathol S; McHugh J; Zajicek C; Shultz LD; Wylie DE
J Immunol; 1997 Sep; 159(6):3024-33. PubMed ID: 9300728
[TBL] [Abstract][Full Text] [Related]
2. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
[TBL] [Abstract][Full Text] [Related]
3. Absence of CD5 dramatically reduces progression of pulmonary inflammatory lesions in SHP-1 protein-tyrosine phosphatase-deficient 'viable motheaten' mice.
Joliat MJ; Lang PA; Lyons BL; Burzenski L; Lynes MA; Yi T; Sundberg JP; Shultz LD
J Autoimmun; 2002 Mar; 18(2):105-17. PubMed ID: 11908943
[TBL] [Abstract][Full Text] [Related]
4. Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain.
Friedmann D; Yachimovich N; Mostoslavsky G; Pewzner-Jung Y; Ben-Yehuda A; Rajewsky K; Eilat D
J Immunol; 1999 Apr; 162(8):4406-16. PubMed ID: 10201976
[TBL] [Abstract][Full Text] [Related]
5. T cell developmental defects in 'viable motheaten' mice deficient in SHP-1 protein-tyrosine phosphatase. Developmental defects are corrected in vitro in the presence of normal hematopoietic-origin stromal cells and in vivo by exogenous IL-7.
Christianson SW; Greiner DL; Deluca D; Leif J; Phillips NE; Hayes SM; Hayashi S; Joliat MJ; Lyons BL; Shultz LD
J Autoimmun; 2002 Mar; 18(2):119-30. PubMed ID: 11908944
[TBL] [Abstract][Full Text] [Related]
6. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice.
Bloom DD; Davignon JL; Cohen PL; Eisenberg RA; Clarke SH
J Immunol; 1993 Feb; 150(4):1579-90. PubMed ID: 8432994
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of autoantibody production in an autoimmune MRL/lpr mouse.
Shan H; Shlomchik MJ; Marshak-Rothstein A; Pisetsky DS; Litwin S; Weigert MG
J Immunol; 1994 Dec; 153(11):5104-20. PubMed ID: 7525723
[TBL] [Abstract][Full Text] [Related]
8. Both Sm and DNA are selecting antigens in the anti-Sm B cell response in autoimmune MRL/lpr mice.
Retter MW; Cohen PL; Eisenberg RA; Clarke SH
J Immunol; 1996 Feb; 156(3):1296-306. PubMed ID: 8558010
[TBL] [Abstract][Full Text] [Related]
9. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene.
Tsui HW; Siminovitch KA; de Souza L; Tsui FW
Nat Genet; 1993 Jun; 4(2):124-9. PubMed ID: 8348149
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of SHP-1 protein-tyrosine phosphatase in "viable motheaten" mice results in retinal degeneration.
Lyons BL; Smith RS; Hurd RE; Hawes NL; Burzenski LM; Nusinowitz S; Hasham MG; Chang B; Shultz LD
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1201-9. PubMed ID: 16505059
[TBL] [Abstract][Full Text] [Related]
11. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice.
Erikson J; Radic MZ; Camper SA; Hardy RR; Carmack C; Weigert M
Nature; 1991 Jan; 349(6307):331-4. PubMed ID: 1898987
[TBL] [Abstract][Full Text] [Related]
12. Molecular properties of anti-DNA induced in preautoimmune NZB/W mice by immunization with bacterial DNA.
Wloch MK; Alexander AL; Pippen AM; Pisetsky DS; Gilkeson GS
J Immunol; 1997 May; 158(9):4500-6. PubMed ID: 9127017
[TBL] [Abstract][Full Text] [Related]
13. Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies.
Krishnan MR; Jou NT; Marion TN
J Immunol; 1996 Sep; 157(6):2430-9. PubMed ID: 8805642
[TBL] [Abstract][Full Text] [Related]
14. B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice.
Roark JH; Kuntz CL; Nguyen KA; Mandik L; Cattermole M; Erikson J
J Immunol; 1995 May; 154(9):4444-55. PubMed ID: 7722301
[TBL] [Abstract][Full Text] [Related]
15. Increased negative selection impairs neonatal B cell repertoire but does not directly lead to generation of disease-associated IgM auto-antibodies.
Cassady-Cain RL; Kaushik AK
Int Immunol; 2006 May; 18(5):661-9. PubMed ID: 16569683
[TBL] [Abstract][Full Text] [Related]
16. Light chain contribution to specificity in anti-DNA antibodies.
Ibrahim SM; Weigert M; Basu C; Erikson J; Radic MZ
J Immunol; 1995 Sep; 155(6):3223-33. PubMed ID: 7673735
[TBL] [Abstract][Full Text] [Related]
17. Autoreactive anti-DNA transgenic B cells in lupus-prone New Zealand black/New Zealand white mice show near perfect L chain allelic exclusion.
Makdasi E; Fischel R; Kat I; Eilat D
J Immunol; 2009 May; 182(10):6143-8. PubMed ID: 19414767
[TBL] [Abstract][Full Text] [Related]
18. Structural and affinity studies of IgM polyreactive natural autoantibodies.
Diaw L; Magnac C; Pritsch O; Buckle M; Alzari PM; Dighiero G
J Immunol; 1997 Jan; 158(2):968-76. PubMed ID: 8993018
[TBL] [Abstract][Full Text] [Related]
19. Molecular dissection of antibody responses against pneumococcal surface protein A: evidence for diverse DH-less heavy chain gene usage and avidity maturation.
Rohatgi S; Dutta D; Tahir S; Sehgal D
J Immunol; 2009 May; 182(9):5570-85. PubMed ID: 19380805
[TBL] [Abstract][Full Text] [Related]
20. A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice.
James JA; Harley JB
J Immunol; 1998 Jan; 160(1):502-8. PubMed ID: 9552009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]